Health Canada
- Status: approved
🇨🇦 vasodilator-based PAH therapy in Canada
vasodilator-based PAH therapy (vasodilator-based PAH therapy) regulatory status in Canada.
Marketing authorisation
vasodilator-based PAH therapy in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is vasodilator-based PAH therapy approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for vasodilator-based PAH therapy in Canada?
Kazuya Hosokawa is the originator. The local marketing authorisation holder may differ — check the official source linked above.